RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SALVATORE D
Collezione AOU Città della Salute di Torino

Items : 9

Post Transplant Cyclophosphamide as GvHD Prophylaxis in Patients Receiving Mismatched Unrelated HCT: the PHYLOS trial. in Blood advances / Blood Adv. 2025 Feb 10:bloodadvances.2024015173. doi: 10.1182/bloodadvances.2024015173.

2025
AOU Città della Salute di Torino

Raiola A; Bruno B; Risitano AM; Mosna F Dr; Cavattoni IM; Onida F; Saporiti GN; Patriarca F; Battista ML; Pavone V; Mele A MD; Chiusolo P; Sica S; Loteta B; di Grazia C; Carella AM; Salvatore D; Morello E; Leoni A; Giaccone L; Bernasconi P; Terruzzi E; Mordini N; Borghero C; Zallio F; Luppi M; Grassi A; Olivieri A; Piras E; et alii...

Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor. in The Journal of pediatrics / J Pediatr. 2024 Nov;274:114176. doi: 10.1016/j.jpeds.2024.114176. Epub 2024 Jun 28.

2024
AOU Città della Salute di Torino

Leonetti G; Costa S; Pantano S; Ficili F; Parisi GF; Salvi M; Troiani P; Vitullo P; Esposito I; Casciaro R; Majo F; Sepe A; Claut L; Daccò V; Castaldo A; Presti S; Fevola C; Terlizzi V; Palladino N; Taccetti G; Bonomi P; Salvatore D;

Corrigendum to "Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 years with Cystic Fibrosis and at Least one F508dek Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor". J Pediatr. 2024 Jun 28; 274:114176. in The Journal of pediatrics / J Pediatr. 2024 Nov;274:114228. doi: 10.1016/j.jpeds.2024.114228. Epub 2024 Aug 28.

2024
AOU Città della Salute di Torino

Leonetti G; Costa S; Pantano S; Ficili F; Parisi GF; Troiani P; Salvi M; Vitullo P; Esposito I; Casciaro R; Majo F; Sepe A; Claut L; Daccò V; Castaldo A; Presti S; Fevola C; Terlizzi V; Palladino N; Taccetti G; Bonomi P; Salvatore D;

Elexacaftor/tezacaftor/ivacaftor in children aged 6-11 years with cystic fibrosis, at least one F508DEL allele, and advanced lung disease: A 24-week observational study. in Pediatric pulmonology / Pediatr Pulmonol. 2022 Sep;57(9):2253-2256. doi: 10.1002/ppul.25980. Epub 2022 May 25.

2022
AOU Città della Salute di Torino

Manunza D; Zanda M; Leonetti G; Esposito I; Bignamini E; Troiani P; Cimino G; Salvatore D; Pepe A;

Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients. in Thyroid : official journal of the American Thyroid Association / Thyroid. 2021 Feb;31(2):264-271. doi: 10.1089/thy.2020.0272. Epub 2020 Jul 1.

2021
AO Ordine Mauriziano
AOU Città della Salute di Torino

Francese C; Ceresini G; Orlandi F; Maniglia CA; Bruno R; Monti S; Santaguida MG; Repaci A; Tallini G; Fugazzola L; Monzani F; Giubbini R; Rossetto R; Mian C; Crescenzi A; Tumino D; Pagano L; Pezzullo L; Lombardi CP; Arvat E; Petrone L; Castagna MG; Spiazzi G; Salvatore D; Meringolo D; Solaroli E; Monari F; Magri F; Triggiani V; et alii...

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study). in Annals of hematology / Ann Hematol. 2019 Feb;98(2):361-367. doi: 10.1007/s00277-018-3524-1. Epub 2018 Oct 23.

2019
AOU Città della Salute di Torino

Caravita T; Reddiconto G; Fragasso A; Di Renzo N; Genuardi M; Bringhen S; Mansueto G; D'Arena G; Pietrantuono G; Villani O; Gagliardi A; Mastrullo L; Catalano L; Salvatore D; Ria R; Conticello C; Di Raimondo F; Cesini L; Petrucci MT; Falcone A; Cascavilla N; Simeon V; Musto P; Scapicchio D; Marziano G; Boccadoro M; Mangiacavalli S; Corso A; Musto P; et alii...

8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2). in Endocrine-related cancer / Endocr Relat Cancer. 2018 Mar;25(3):L7-L11. doi: 10.1530/ERC-17-0453. Epub 2017 Nov 30.

2018
AO Ordine Mauriziano
AOU Città della Salute di Torino

Durante C; Lucisano G; Filetti S; Castagna MG; Salvatore D; Nicolucci A; Centanni M; Meringolo D; Rossetto R; Tumino S; Ceresini G; Bruno R; Pagano L; Daniele L; Fugazzola L; Montesano T; Pontecorvi A; Bellantone R; Torlontano M; Massa M; Morelli S; Puxeddu E; Zatelli MC; Rossi R; Nervo A; Arvat E; Grani G; Lamartina L;

Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. in Haematologica / Haematologica. 2018 Aug;103(8):1317-1328. doi: 10.3324/haematol.2018.189258. Epub 2018 May 10.

2018
AOU Città della Salute di Torino

Huynh A; Bruno B; Van Lint MT; Bourhis JH; Sociè G; Arcese W; Blaise D; Ciceri F; Ghavamzadeh A; Battipaglia G; Ruggeri A; Labopin M; Salvatore D; Santarone S; Deconinck E; Mohty M; Nagler A; Salvatore D; Labopin M; Ruggeri A; Battipaglia G; Ghavamzadeh A; Ciceri F; Blaise D; Arcese W; Sociè G; Bourhis JH; Van Lint MT; Bruno B; et alii...

Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory. in Thyroid : official journal of the American Thyroid Association / Thyroid. 2017 Dec;27(12):1490-1497. doi: 10.1089/thy.2017.0299. Epub 2017 Nov 10.

2017
AO Ordine Mauriziano
AOU Città della Salute di Torino

Salvatore D; Monti S; Centanni M; Ceresini G; Tumino S; Bruno R; Meringolo D; Fugazzola L; Rossetto R; Limone P; Antonelli A; Attard M; Francese C; Monzani F; Aimaretti G; Orlandi F; Giubbini R; Montesano T; Crocetti U; Torlontano M; Morelli S; Rossi R; Puxeddu E; Zatelli MC; Felicetti F; Arvat E; Pontecorvi A; Lombardi CP; Bellantone R; et alii...